Cell Bio Human Tech Co.,Ltd (KOSDAQ:318160)

KOSDAQ:318160 Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3,273	3,099	4,052	4,495	13,929	6,252
Short-Term Investments	8,589	11,207	9,433	2,400	7,463	6,396
Cash & Short-Term Investments	11,862	14,306	13,485	6,895	21,392	12,649
Cash Growth	-26.81%	6.09%	95.59%	-67.77%	69.12%	-57.70%
Accounts Receivable	5,310	4,014	4,241	3,072	3,584	4,623
Other Receivables	75.18	34.96	96.49	32.52	154.82	1,001
Receivables	5,385	4,049	4,337	3,104	3,739	5,624
Inventory	6,334	4,550	8,281	9,106	6,254	4,389
Prepaid Expenses	788.63	459.29	308.51	281.85	55.4	14.22
Other Current Assets	1,316	628.87	506.67	548.41	630.85	730.2
Total Current Assets	25,685	23,992	26,918	19,936	32,071	23,406
Property, Plant & Equipment	25,568	24,568	22,764	23,152	23,904	20,983
Long-Term Investments	1,350	1,034	644.17	548.66	509.54	1,932
Goodwill	-	-	-	-	-	220.31
Other Intangible Assets	1,246	1,255	1,282	818.32	817.77	724.56
Long-Term Deferred Tax Assets	-	457.97	557.14	825.57	248.83	27.4
Other Long-Term Assets	1,650	1,597	1,030	701.66	517.12	602.47
Total Assets	55,499	52,905	53,196	45,982	58,069	47,896
Accounts Payable	1,205	837.06	1,048	861.03	1,953	1,387
Accrued Expenses	659.77	600.95	564.82	709.24	414.39	498.58
Short-Term Debt	3,656	3,675	5,875	4,942	4,735	-
Current Portion of Leases	231.82	217.95	29.73	220.38	233.33	236.73
Current Income Taxes Payable	369.25	462.79	540.81	573.6	1,449	263.54
Other Current Liabilities	1,852	490	499.72	441.35	833.07	799.12
Total Current Liabilities	7,974	6,284	8,559	7,748	9,617	3,185
Long-Term Debt	-	-	-	-	9,421	-
Long-Term Leases	132.69	174.56	21.89	68.78	274.54	459.18
Other Long-Term Liabilities	37.57	34.84	53.07	60.34	29.76	39.36
Total Liabilities	8,144	6,493	8,634	7,877	19,342	3,684
Common Stock	4,630	4,630	4,630	4,100	4,100	4,100
Additional Paid-In Capital	23,835	23,835	23,835	18,077	18,077	18,070
Retained Earnings	19,373	17,995	13,616	21,086	31,294	28,163
Treasury Stock	-3,937	-2,833	-37.25	-7,916	-7,916	-7,916
Comprehensive Income & Other	2,974	2,338	2,072	-3,648	-17,136	1,227
Total Common Equity	46,875	45,965	44,116	31,700	28,420	43,644
Minority Interest	33.27	-	-	-	-	121.62
Shareholders' Equity	47,355	46,412	44,563	38,105	38,726	44,213
Total Liabilities & Equity	55,499	52,905	53,196	45,982	58,069	47,896
Total Debt	4,020	4,068	5,927	5,232	14,663	695.91
Net Cash (Debt)	7,842	10,238	7,558	1,663	6,728	11,953
Net Cash Growth	-22.24%	35.46%	354.48%	-75.28%	-43.71%	-59.35%
Net Cash Per Share	899.22	1147.60	894.55	237.54	852.31	1484.50
Filing Date Shares Outstanding	8.26	8.54	9.26	7	7	7.16
Total Common Shares Outstanding	8.26	8.54	9.26	7	7	7.16
Working Capital	17,711	17,709	18,359	12,187	22,454	20,221
Book Value Per Share	5671.60	5383.59	4765.58	4527.97	4059.42	6096.97
Tangible Book Value	45,629	44,710	42,834	30,882	27,602	42,700
Tangible Book Value Per Share	5520.84	5236.55	4627.08	4411.09	3942.62	5964.98
Land	-	2,360	2,360	2,360	2,360	2,360
Buildings	-	8,986	8,442	8,459	8,282	422.5
Machinery	-	11,565	10,287	10,742	10,622	5,304
Construction In Progress	-	766.68	128.07	30.27	310.99	11,915

Source: S&P Global Market Intelligence. Standard template. Financial Sources.